Unknown

Dataset Information

0

An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis.


ABSTRACT: Gallbladder cancer (GBC) has a lower incidence rate among the population relative to other cancer types but is a major contributor to the total number of biliary tract system cancer cases. GBC is distinguished from other malignancies by its high mortality, marked geographical variation and poor prognosis. To date no systemic targeted therapy is available for GBC. The main objective of this study is to determine the molecular signatures correlated with GBC development using integrative systems level approaches. We performed analysis of publicly available transcriptomic data to identify differentially regulated genes and pathways. Differential co-expression network analysis and transcriptional regulatory network analysis was performed to identify hub genes and hub transcription factors (TFs) associated with GBC pathogenesis and progression. Subsequently, we assessed the epithelial-mesenchymal transition (EMT) status of the hub genes using a combination of three scoring methods. The identified hub genes including, CDC6, MAPK15, CCNB2, BIRC7, L3MBTL1 were found to be regulators of cell cycle components which suggested their potential role in GBC pathogenesis and progression.

SUBMITTER: Roy N 

PROVIDER: S-EPMC8397040 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

An Integrative Systems Biology Approach Identifies Molecular Signatures Associated with Gallbladder Cancer Pathogenesis.

Roy Nabanita N   Kshattry Mrinmoy M   Mandal Susmita S   Jolly Mohit Kumar MK   Bhattacharyya Dhruba Kumar DK   Barah Pankaj P  

Journal of clinical medicine 20210810 16


Gallbladder cancer (GBC) has a lower incidence rate among the population relative to other cancer types but is a major contributor to the total number of biliary tract system cancer cases. GBC is distinguished from other malignancies by its high mortality, marked geographical variation and poor prognosis. To date no systemic targeted therapy is available for GBC. The main objective of this study is to determine the molecular signatures correlated with GBC development using integrative systems le  ...[more]

Similar Datasets

| S-EPMC3526425 | biostudies-other
2012-11-09 | E-GEOD-32959 | biostudies-arrayexpress
2025-02-07 | GSE261878 | GEO
2012-11-09 | GSE32959 | GEO
| S-EPMC5884799 | biostudies-literature
| S-EPMC6406733 | biostudies-literature
| S-BSST1165 | biostudies-other
| S-BSST1216 | biostudies-other
2025-02-07 | GSE261775 | GEO
| S-EPMC3901372 | biostudies-literature